2015 annual financial data
Sarepta Therapeutics 2015 Operating cash flow margin
Direct answer
Operating cash flow margin was -11,928.57%.
Operating income was -220,184,000 USD and net income was -220,030,000 USD.
Operating cash flow was -149,465,000 USD.
Get free Sarepta Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,253,000 USD
- Operating income
- -220,184,000 USD
- Net income
- -220,030,000 USD
- Operating cash flow
- -149,465,000 USD